Literature DB >> 1085628

Lymphocyte response to mitogens in progressive systemic sclerosis.

N B Salem, J H Morse.   

Abstract

Lymphocyte responses to the mitogens phytohemagglutinin P(PHA-P), concanavallin A (Con A), and pokeweed (PWM) were studied in 18 patients with progressive systemic sclerosis (PSS). A subgroup of these patients with multisystem involvement showed a significantly decreased lymphocyte response to both Con A and PWM when compared to normal controls. However those PSS patients with myositis, although having multisystem involvement, had normal lymphocyte response to all three mitogens. PHA-P stumulation was normal in all PSS patients. Antinuclear antibodies, elevated sedimentation rates, and positive latex fixation were noted only in the multisystem disease group with abnormal lymphocyte function.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1085628     DOI: 10.1002/art.1780190507

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  10 in total

1.  Inhibition of lymphocyte proliferation stimulated by lectins and allogeneic cells by normal plasma lipoproteins.

Authors:  J H Morse; L D Witte; D S Goodman
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

Review 2.  Pathogenesis of scleroderma: the interrelationship of the immune and vascular hypotheses.

Authors:  E M Sternberg
Journal:  Surv Immunol Res       Date:  1985

3.  Familial progressive systemic sclerosis (scleroderma): immunological analysis of two patients and six siblings from a single kindred.

Authors:  E Soppi; A Lehtonen; A Toivanen
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

4.  Defective Epstein-Barr virus specific suppressor T cell function in progressive systemic sclerosis.

Authors:  A Kahan; A Kahan; C J Menkes; B Amor
Journal:  Ann Rheum Dis       Date:  1986-07       Impact factor: 19.103

5.  Subpopulations of human T lymphocytes. IX. Imbalance of T cell subpopulations in patients with progressive systemic sclerosis.

Authors:  S Gupta; A N Malaviya; P Rajagopalan; R A Good
Journal:  Clin Exp Immunol       Date:  1979-11       Impact factor: 4.330

6.  Prostaglandin E1 infusions for vascular insufficiency in progressive systemic sclerosis.

Authors:  M F Martin; P M Dowd; E F Ring; E D Cooke; P A Dieppe; J D Kirby
Journal:  Ann Rheum Dis       Date:  1981-08       Impact factor: 19.103

7.  Lymphocyte subpopulations and reactivity to mitogens in patients with scleroderma.

Authors:  M Baron; E C Keystone; D D Gladman; P Lee; L Poplonski
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

8.  The mitogenic effect of the lymphocytosis promoting factor from Bordetella pertussis on human lymphocytes.

Authors:  J H Morse; A S Kong; J Lindenbaum; S I Morse
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

9.  Monocyte-induced inhibition of lymphocyte response to phytohaemagglutinin in progressive systemic sclerosis.

Authors:  M D Lockshin; J A Markenson; L Fuzesi; S Kazanjian-Aram; C Joachim; M Ordene
Journal:  Ann Rheum Dis       Date:  1983-02       Impact factor: 19.103

10.  Measurement of clinical change in progressive systemic sclerosis: a 1 year double-blind placebo-controlled trial of N-acetylcysteine.

Authors:  D E Furst; P J Clements; R Harris; M Ross; J Levy; H E Paulus
Journal:  Ann Rheum Dis       Date:  1979-08       Impact factor: 19.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.